Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Research from the US provides evidence of the harm of patients choosing alternative therapy and declining conventional treatments and the impact on survival.
Professor Jack Cuzick has received our Lifetime Achievement Award for his work on cancer prevention and detection.
Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.
A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.
Category: Science blog April 19, 2017
Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.
Category: Science blog March 24, 2017
We’re backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.
In part 3 of our World Cancer Day series, we take a look at how liver cancer affects different regions across the world.
For this year’s World Cancer Day we’re looking at how the rates of 4 types of cancer vary around the world, and why.